+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Diabetic Macular Edema Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • PDF Icon

    Report

  • 119 Pages
  • August 2022
  • Region: Global
  • Acute Market Reports
  • ID: 5713526
Description Jump to:
World Health Organization 2018 survey states that globally around 422 million people suffer with diabetes and approximately 2.6 % of the global blindness is due to diabetic retinopathy. The American Academy of Ophthalmology has stated that the incidence rate of diabetic macular edema in a span of 10 years to be 20 % in younger patients and 40 % in older patients. Currently combined therapy of photocoagulation laser therapy and Anti-VEGF drugs are employed to achieve improved vision and avoid blindness. The drugs in phase III clinical trials such as conbercept, pemofibrate, ranibizumab and aflibercept intravitreal injection are tested for better drug efficacy.

Therapy segment for the diabetic macular edema treatment market majorly comprises drugs and surgery. The drugs are further sub segmented as Anti-VEGF, Corticosteroids and other drugs (Triamcinolone Acetonide and Bevacizumab). Anti-VEGF treatment adopted is Ranibizumab and Aflibercept. Corticosteroids includes dexamethasone and Fluocinolone Acetonide. The surgery segment comprises of photocoagulation laser therapy and intravitreal implants. In order to understand the current trend existing in the market the data forecast and market estimation for treatment segment is given in the scope of the report.

Competitive landscape is an assessment tool highlights the performance of the fundamental players currently engaged in the diabetic macular edema treatment market. The parameters employed are geographical presence, product portfolio and inception. Company profiles gives a brief update regarding the latest technological advancement in the photocoagulation laser therapy market and effective collaboration among niche players. The fundamental players in the diabetic macular edema treatment market are Allergan, Inc., Quantel-Medical, Alimera Sciences, Bausch and Lomb Incorporated, Carl Zeiss Meditec AG, Ellex, Genetech, Inc., IRIDEX Corporation, LUMENIS, Novartis AG, and Regeneron Pharmaceuticals, Inc.

Diabetic macular edema is a complication seen in patients suffering with diabetic retinopathy in which the blood vessels of macula region of retina are damaged and allows the fluid to escape. It is prevalent in two forms as focal diabetic macular edema which employs surgical treatment options and diffuse macular edema which is taken care by drug therapy. Photocoagulation laser therapy is utilized as a standard treatment protocol in patients suffering with blurred visions and double visions. The yellow pattern 577 nm micropulse laser is preferred to the conventional green pattern 532 wavelength due to less thermal absorption by the xanthophyll pigments. Post 2005 the anti-VEGF drug treatment has been considered as the first line of treatment for diabetic macular edema as it inhibits various isoforms of VEGF thus enhancing vision and preventing blindness. Intravitreal implants will be the trendsetter during the forecast duration 2020-2030; Retisert, Illuvien and Ozurdex will provide high drug efficacy and safety. The prominent players in diabetic macular edema treatment market are Allergan, Inc., Alimera Sciences, Bausch and Lomb Incorporated, Carl Zeiss Meditec AG, Ellex, Genetech, Inc., IRIDEX Corporation, LUMENIS, Novartis AG, Quantel-Medical and Regeneron Pharmaceuticals, Inc.

As per the research finding of Center for Disease Control and Prevention 2019, there were around 4.2 million people suffering with diabetic retinopathy with 655,000 of them suffering with diabetic retinopathy. The increasing number of U.S. citizens being diagnosed for type 2 diabetes and the recent USFDA approval for intravitreal implants such as Iluvien, Eylea and Ozurdex will contribute to the assist the growth of North American diabetic macular edema treatment market. The Western European region shows remarkable growth in the diabetic macular edema treatment market due to presence of cardinal players and prolific investment in the research and development segment to develop intravitreal implants. Asia Pacific reflects a balanced growth as a result of the competitive market created by the global and domestic manufacturers of photocoagulation lasers. In addition the supportive regulatory environment for the drug therapies and intravitreal implants have a positive impact on Asia Pacific market. Proactive role played by government healthcare agencies to promote eyecare and increasing eyesight awareness campaign conducted by major players will thrust the diabetic macular edema treatment market growth in the Middle East and Latin America.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Diabetic Macular Edema Treatment market are as follows:
  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Diabetic Macular Edema Treatment market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Treatment

  • Drugs
  • Anti-VEGF
  • Ranibizumab
  • Aflibercept
  • Corticosteroids
  • Fluocinolone Acetonide
  • Dexamethasone
  • Others (Triamcinolone Acetonide, Bevacizumab)
  • Surgery
  • Photocoagulation Laser Therapy
  • Intravitreal Implants
  • Pipeline Analysis
  • Phase III Drugs
  • Conbercept
  • Pemofibrate
  • O.3mg Ranibizumab Intravitreal Injection
  • 2mg Aflibercept Intravitreal Injection

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Diabetic Macular Edema Treatment market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2030.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Diabetic Macular Edema Treatment market?
  • Which is the largest regional market for Diabetic Macular Edema Treatment market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Diabetic Macular Edema Treatment market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Diabetic Macular Edema Treatment market worldwide?


This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Diabetic Macular Edema Treatment Market
2.2. Global Diabetic Macular Edema Treatment Market, By Treatment, 2021 (US$ Million)
2.3. Global Diabetic Macular Edema Treatment Market, By Geography, 2021 (US$ Million)
2.4. Attractive Investment Proposition by Geography, 2021

3. Diabetic Macular Edema Treatment Market: Competitive Analysis
3.1. Market Positioning of Key Diabetic Macular Edema Treatment Market Vendors
3.2. Strategies Adopted by Diabetic Macular Edema Treatment Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2021 Versus 2030

4. Diabetic Macular Edema Treatment Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Diabetic Macular Edema Treatment Market Value, 2020 - 2030, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis

5. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2021 Versus 2030
5.3. Market Segmentation
5.3.1. Drugs
5.3.1.1. Anti-VEGF
5.3.1.1.1. Ranibizumab
5.3.1.1.2. Aflibercept
5.3.1.2. Corticosteroids
5.3.1.2.1. Fluocinolone Acetonide
5.3.1.2.2. Dexamethasone
5.3.1.3. Others (Triamcinolone Acetonide, Bevacizumab)
5.3.2. Surgery
5.3.2.1. Photocoagulation Laser Therapy
5.3.2.2. Intravitreal Implants
5.3.3. Pipeline Analysis
5.3.3.1. Phase III Drugs
5.3.3.2. Conbercept
5.3.3.3. Pemofibrate
5.3.3.4. O.3mg Ranibizumab Intravitreal Injection
5.3.3.5. 2mg Aflibercept Intravitreal Injection

6. North America Diabetic Macular Edema Treatment Market, 2020-2030, USD (Million)
6.1. Market Overview
6.2. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
6.3.Diabetic Macular Edema Treatment Market: By Region, 2020-2030, USD (Million)
6.3.1.North America
6.3.1.1. U.S.
6.3.1.1.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
6.3.1.2. Canada
6.3.1.2.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
6.3.1.3. Rest of North America
6.3.1.3.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)

7. UK and European Union Diabetic Macular Edema Treatment Market, 2020-2030, USD (Million)
7.1. Market Overview
7.2. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
7.3.Diabetic Macular Edema Treatment Market: By Region, 2020-2030, USD (Million)
7.3.1.UK and European Union
7.3.1.1. UK
7.3.1.1.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
7.3.1.2. Germany
7.3.1.2.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
7.3.1.3. Spain
7.3.1.3.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
7.3.1.4. Italy
7.3.1.4.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
7.3.1.5. France
7.3.1.5.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
7.3.1.6. Rest of Europe
7.3.1.6.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)

8. Asia Pacific Diabetic Macular Edema Treatment Market, 2020-2030, USD (Million)
8.1. Market Overview
8.2. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
8.3.Diabetic Macular Edema Treatment Market: By Region, 2020-2030, USD (Million)
8.3.1.Asia Pacific
8.3.1.1. China
8.3.1.1.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
8.3.1.2. Japan
8.3.1.2.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
8.3.1.3. India
8.3.1.3.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
8.3.1.4. Australia
8.3.1.4.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
8.3.1.5. South Korea
8.3.1.5.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
8.3.1.6. Rest of Asia Pacific
8.3.1.6.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)

9. Latin America Diabetic Macular Edema Treatment Market, 2020-2030, USD (Million)
9.1. Market Overview
9.2. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
9.3.Diabetic Macular Edema Treatment Market: By Region, 2020-2030, USD (Million)
9.3.1.Latin America
9.3.1.1. Brazil
9.3.1.1.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
9.3.1.2. Mexico
9.3.1.2.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
9.3.1.3. Rest of Latin America
9.3.1.3.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)

10. Middle East and Africa Diabetic Macular Edema Treatment Market, 2020-2030, USD (Million)
10.1. Market Overview
10.2. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
10.3.Diabetic Macular Edema Treatment Market: By Region, 2020-2030, USD (Million)
10.3.1.Middle East and Africa
10.3.1.1. GCC
10.3.1.1.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
10.3.1.2. Africa
10.3.1.2.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
10.3.1.3. Rest of Middle East and Africa
10.3.1.3.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)

11. Company Profile
11.1. Allergan, Inc.
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Portfolio
11.1.4. Strategic Initiatives
11.2. Alimera Sciences
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Portfolio
11.2.4. Strategic Initiatives
11.3. Bausch and Lomb Incorporated
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Portfolio
11.3.4. Strategic Initiatives
11.4. Carl Zeiss Meditec AG
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Portfolio
11.4.4. Strategic Initiatives
11.5. Ellex
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Portfolio
11.5.4. Strategic Initiatives
11.6. Genetech, Inc.
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Portfolio
11.6.4. Strategic Initiatives
11.7. IRIDEX Corporation
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Portfolio
11.7.4. Strategic Initiatives
11.8. LUMENIS
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Portfolio
11.8.4. Strategic Initiatives
11.9. Novartis AG
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Portfolio
11.9.4. Strategic Initiatives
11.10. Quantel-Medical
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Portfolio
11.10.4. Strategic Initiatives
11.11. Regeneron Pharmaceuticals, Inc.
11.11.1. Company Overview
11.11.2. Financial Performance
11.11.3. Product Portfolio
11.11.4. Strategic Initiatives

List of Figures
Figure 1 Global Diabetic Macular Edema Treatment Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Diabetic Macular Edema Treatment Market: Quality Assurance
Figure 5 Global Diabetic Macular Edema Treatment Market, By Treatment, 2021
Figure 6 Global Diabetic Macular Edema Treatment Market, By Geography, 2021
Figure 7 Market Geographical Opportunity Matrix - Global Diabetic Macular Edema Treatment Market, 2021
Figure 8 Market Positioning of Key Diabetic Macular Edema Treatment Market Players, 2021
Figure 9 Global Diabetic Macular Edema Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
Figure 10 Global Diabetic Macular Edema Treatment Market, By Treatment, 2021 Vs 2030, %
Figure 11 U.S. Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
Figure 12 Canada Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
Figure 13 Rest of North America Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
Figure 14 UK Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
Figure 15 Germany Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
Figure 16 Spain Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
Figure 17 Italy Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
Figure 18 France Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
Figure 19 Rest of Europe Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
Figure 20 China Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
Figure 21 Japan Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
Figure 22 India Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
Figure 23 Australia Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
Figure 24 South Korea Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
Figure 25 Rest of Asia Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
Figure 26 Brazil Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
Figure 27 Mexico Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
Figure 28 Rest of Latin America Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
Figure 29 GCC Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
Figure 30 Africa Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
Figure 31 Rest of Middle East and Africa Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030

List of Tables
Table 1 Global Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 2 Global Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
Table 3 Global Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
Table 4 Global Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
Table 5 Global Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
Table 6 Global Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 7 North America Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 8 North America Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
Table 9 North America Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
Table 10 North America Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
Table 11 North America Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
Table 12 North America Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 13 U.S. Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 14 U.S. Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
Table 15 U.S. Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
Table 16 U.S. Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
Table 17 U.S. Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
Table 18 U.S. Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 19 Canada Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 20 Canada Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
Table 21 Canada Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
Table 22 Canada Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
Table 23 Canada Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
Table 24 Canada Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 25 Rest of North America Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 26 Rest of North America Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
Table 27 Rest of North America Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
Table 28 Rest of North America Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
Table 29 Rest of North America Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
Table 30 Rest of North America Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 31 UK and European Union Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 32 UK and European Union Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
Table 33 UK and European Union Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
Table 34 UK and European Union Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
Table 35 UK and European Union Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
Table 36 UK and European Union Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 37 UK Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 38 UK Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
Table 39 UK Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
Table 40 UK Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
Table 41 UK Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
Table 42 UK Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 43 Germany Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 44 Germany Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
Table 45 Germany Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
Table 46 Germany Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
Table 47 Germany Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
Table 48 Germany Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 49 Spain Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 50 Spain Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
Table 51 Spain Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
Table 52 Spain Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
Table 53 Spain Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
Table 54 Spain Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 55 Italy Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 56 Italy Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
Table 57 Italy Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
Table 58 Italy Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
Table 59 Italy Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
Table 60 Italy Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 61 France Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 62 France Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
Table 63 France Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
Table 64 France Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
Table 65 France Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
Table 66 France Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 67 Rest of Europe Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 68 Rest of Europe Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
Table 69 Rest of Europe Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
Table 70 Rest of Europe Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
Table 71 Rest of Europe Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
Table 72 Rest of Europe Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 73 Asia Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 74 Asia Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
Table 75 Asia Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
Table 76 Asia Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
Table 77 Asia Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
Table 78 Asia Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 79 China Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 80 China Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
Table 81 China Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
Table 82 China Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
Table 83 China Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
Table 84 China Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 85 Japan Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 86 Japan Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
Table 87 Japan Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
Table 88 Japan Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
Table 89 Japan Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
Table 90 Japan Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 91 India Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 92 India Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
Table 93 India Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
Table 94 India Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
Table 95 India Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
Table 96 India Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 97 Australia Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 98 Australia Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
Table 99 Australia Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
Table 100 Australia Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
Table 101 Australia Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
Table 102 Australia Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 103 South Korea Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 104 South Korea Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
Table 105 South Korea Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
Table 106 South Korea Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
Table 107 South Korea Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
Table 108 South Korea Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 109 Latin America Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 110 Latin America Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
Table 111 Latin America Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
Table 112 Latin America Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
Table 113 Latin America Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
Table 114 Latin America Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 115 Brazil Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 116 Brazil Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
Table 117 Brazil Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
Table 118 Brazil Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
Table 119 Brazil Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
Table 120 Brazil Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 121 Mexico Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 122 Mexico Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
Table 123 Mexico Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
Table 124 Mexico Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
Table 125 Mexico Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
Table 126 Mexico Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 127 Rest of Latin America Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 128 Rest of Latin America Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
Table 129 Rest of Latin America Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
Table 130 Rest of Latin America Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
Table 131 Rest of Latin America Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
Table 132 Rest of Latin America Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 133 Middle East and Africa Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 134 Middle East and Africa Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
Table 135 Middle East and Africa Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
Table 136 Middle East and Africa Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
Table 137 Middle East and Africa Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
Table 138 Middle East and Africa Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 139 GCC Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 140 GCC Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
Table 141 GCC Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
Table 142 GCC Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
Table 143 GCC Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
Table 144 GCC Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 145 Africa Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 146 Africa Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
Table 147 Africa Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
Table 148 Africa Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
Table 149 Africa Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
Table 150 Africa Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
Table 151 Rest of Middle East and Africa Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 152 Rest of Middle East and Africa Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
Table 153 Rest of Middle East and Africa Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
Table 154 Rest of Middle East and Africa Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
Table 155 Rest of Middle East and Africa Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
Table 156 Rest of Middle East and Africa Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)

Companies Mentioned

  • Allergan Inc.
  • Alimera Sciences
  • Bausch and Lomb Incorporated
  • Carl Zeiss Meditec AG
  • Ellex
  • Genetech Inc.
  • IRIDEX Corporation
  • LUMENIS
  • Novartis AG
  • Quantel-Medical
  • Regeneron Pharmaceuticals Inc.

Related Topics

Related Reports

Diabetic Macular Edema Treatment - Global Strategic Business Report - Product Image

Diabetic Macular Edema Treatment - Global Strategic Business Report

  • Report
  • 192 Pages
  • Global
From
Diabetic Macular Edema Treatment Market by Treatment, End-User - Global Forecast 2025-2030 - Product Image

Diabetic Macular Edema Treatment Market by Treatment, End-User - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Non-Infectious Macular Edema Treatment - Global Strategic Business Report - Product Image

Non-Infectious Macular Edema Treatment - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Non-infectious Macular Edema Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Non-infectious Macular Edema Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 323 Pages
  • Global
Macular Edema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Macular Edema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 132 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.